ID™ SARS-CoV-2 / Influenza Triplex RT-PCR

Triplex RT-PCR test allowing for the detection and differentiation of SARS-CoV-2 and Influenza A/B viruses in humans.

Qualitative triplex RT-PCR which simultaneously amplifies SARS-CoV-2, Influenza A and Influenza B target sequences and an endogenous internal control.

This test was developed by Innovative Diagnostics’ sister company: ID-Solutions, which is specialized in circulating DNA diagnostics in human oncology. The test is CE-IVD marked.

  • High sensitivity: LOD(95%) is < 12 copies/PCR
  • Positive Extraction Control (PEC): unique on the market, for the validation of the extraction process and reverse transcriptase step
  • Endogenous internal control to ensure sample presence and the absence of false negatives
  • Ready-to-use
  • Results are obtained within 1 hour
  • Validated on the main thermocyclers on the market
Nos tests de diagnostic sont conçus pour une utilisation en laboratoire par du personnel qualifié. Ils sont fournis exclusivement aux laboratoires et ne sont pas distribués aux particuliers.
Si vous souhaitez savoir si vous avez contracté la Covid-19, veuillez vous rapprocher de votre médecin traitant.


Method RT-PCR - Triplex - Qualitative
Species Humans
Sample types Nasopharyngeal, oropharyngeal swabs or sputum samples

Ordering information

Product code Reactions
IDRESPI-P1-100 100
IDRESPI-P1-500 500

Associated products